Inotiv, Inc. — Director's Dealing 2021

Mar 5, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOANALYTICAL SYSTEMS INC (BASI)
CIK: 0000720154
Period of Report: 2021-03-05

Reporting Person: Taylor Beth (VP- Finance & CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-05	Common Shares	P	5000	$17.70	Acquired	34295	Direct

Footnotes

F1: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.44 to $17.85. The reporting person undertakes to provide Bioanalytical Systems, Inc., any security holder of Bioanalytical Systems, Inc. or the staff of the Securities & Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.